Join
Live feed
·
INSIDERFilingvia Quantisnow
Alterity Therapeutics Limited logo

Director Marks Peter Ashley bought $23,810 worth of Ordinary shares (47,620 units at $0.50) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATHE· Alterity Therapeutics Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATHE (Alterity Therapeutics Limited) and more on Quantisnow.